6 records totalling $747,290.00 CAD, from official Government of Canada open data.
| National Research Council Canada | $747,290 | 6 records |
Firm would like to design and develop novel EGFR (epidermal growth factor receptor) inhibitor cancer therapeutic that improve selectivity to allow irreversible inhibition to overcome resistance mutati...
The proposed project will address re-synthesis of at least one active compounds proprietary to the Firm that have been demonstrated to have vaccine adjuvant properties. Sufficient quantity of these a...
Firm would like to design and develop novel EGFR (epidermal growth factor receptor) inhibitor cancer therapeutic that improve selectivity to allow irreversible inhibition to overcome resistance mutati...